Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease

PLoS ONE - United States
doi 10.1371/journal.pone.0023379
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Tuberous Sclerosis Complex-Associated Renal Angiomyolipomas: A Single Center Study of 17�consecutive Cases

Oncology Letters
Cancer ResearchOncology
2016English

Acute Retroperitoneal Hematoma Mimicking Intraperitoneal Hemorrhage Caused by Renal Angiomyolipomas Associated With Tuberous Sclerosis

Gaziantep Medical Journal
2012English

Treatment of Voluminous and Complicated Superficial Slow-Flow Vascular Malformations With Sirolimus (PERFORMUS): Protocol for a Multicenter Phase 2 Trial With a Randomized Observational-Phase Design

Trials
MedicinePharmacology
2018English

GP289 Kidney Involvement in Tuberous Sclerosis Complex

2019English

Diagnosis and Treatment of Tuberous Sclerosis Manifestations in Children: A Multicenter Study

Neuropediatrics
MedicineChild HealthNeurologyPediatricsPerinatology
2018English

Glucose Deprivation in Tuberous Sclerosis Complex-Related Tumors

Cell and Bioscience
BiochemistryGeneticsMolecular Biology
2011English

Tuberous Sclerosis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1995English

A Randomized Controlled Trial With Everolimus for IQ and Autism in Tuberous Sclerosis Complex

Neurology
Neurology
2019English

Tuberous Sclerosis

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy